Get the tools used by (smart)2 investors.

Predicted Market Cap / Fwd FFO (FY+2) for ANI Pharmaceuticals Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ANIP: ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides i...

67.61 USD
Price
USD
Fair Value
Upside
52.50 - 70.05
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on ANI Pharmaceuticals Inc's Predicted Market Cap / Fwd FFO (FY+2):

ANIPHLTH.USCOLLPBHAQSTASRTTLPH0.0x

Performance Summary
  • ANI Pharmaceuticals's predicted market cap / fwd ffo (fy+2) is 0.0x

How does ANI Pharma's Predicted Market Cap / Fwd FFO (FY+2) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to ANI Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Predicted Market Cap / Fwd FFO (FY+2)

Hide this widget
prediction_market_to_ffo_fwd2
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Predicted Market Cap / Fwd FFO (FY+2) in the predictions category include:

  • EPV Fair Value - Our estimate of fair value for a company using earnings power value method.
  • Number of Outperform Recommendations - The number of analysts publishing an Outperform recommendation for the stock.
  • Analyst Price Target Count - The number of analyst price targets tracked for a stock. Price targets represent what analysts believe a stock will be worth within the next 12 to 18 months.
  • Analyst Price Target Low - The lowest analyst price target for a stock. Price targets represent what analysts believe a stock will be worth within the next 12 to 18 months.
View Full List

Search for metric or datapoint

Predicted Market Cap / Fwd FFO (FY+2)

Our estimate of the fair value Market Cap / Fwd FFO (FY+2) for a REIT.

Definition of Predicted Market Cap / Fwd FFO (FY+2)

Hide this widget
Our estimate of the fair value Market Cap / Fwd FFO (FY+2) for a REIT.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0.0x0.3x0.5x0.8x1.0x01,0002,000

The chart above depicts the distribution of predicted market cap / fwd ffo (fy+2) for companies operating in the Healthcare sector in the Developed economic region. Over 2,475 companies were considered in this analysis, and 2,479 had meaningful values. The average predicted market cap / fwd ffo (fy+2) of companies in the sector is 0.0x with a standard deviation of 0.0x.

ANI Pharmaceuticals Inc's Predicted Market Cap / Fwd FFO (FY+2) of 0.0x ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:

Predicted Market Cap / Fwd FFO (FY+2) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,480
Included Constituents2,479
Min0.0x
Max0.0x
Median0.0x
Mean0.0x
Standard Deviation0.0x

You can find companies with similar predicted market cap / fwd ffo (fy+2) using this stock screener.

All rights reserved. Terms Of Use